Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 469, doi. 10.1007/s00262-014-1533-z
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 5
Results: 10
1
2
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 513, doi. 10.1007/s00262-014-1527-x
- By:
- Publication type:
- Article
3
Interleukin 12: still a promising candidate for tumor immunotherapy?
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 419, doi. 10.1007/s00262-014-1523-1
- By:
- Publication type:
- Article
4
Alterations of costimulatory molecules and instructive cytokines expressed by dendritic cells in the microenvironment of an endogenous mouse lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 491, doi. 10.1007/s00262-014-1538-7
- By:
- Publication type:
- Article
5
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 459, doi. 10.1007/s00262-014-1531-1
- By:
- Publication type:
- Article
6
ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 437, doi. 10.1007/s00262-014-1525-z
- By:
- Publication type:
- Article
7
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9-11, 2013.
- Published in:
- 2014
- By:
- Publication type:
- Report
8
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 501, doi. 10.1007/s00262-014-1536-9
- By:
- Publication type:
- Article
9
P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 479, doi. 10.1007/s00262-014-1529-8
- By:
- Publication type:
- Article
10
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 449, doi. 10.1007/s00262-014-1528-9
- By:
- Publication type:
- Article